Artiva Biotherapeutics (ARTV) Receivables (2023 - 2025)

Artiva Biotherapeutics (ARTV) reported Receivables of $67000.0 for Q4 2025, down 54.11% year-over-year from $146000.0 in Q4 2024, and down 15.19% quarter-over-quarter from $79000.0 in Q3 2025.

Artiva Biotherapeutics (ARTV) Receivables (2023 - 2025) Analysis & Trends

Artiva Biotherapeutics (ARTV) has 3 years of Receivables data on file, last reported at $67000.0 in Q4 2025.

  • Receivables for Q4 2025 came in at $67000.0, down 54.11% year-over-year; the trailing twelve-month figure through Dec 2025 was $67000.0 (down 54.11% YoY), and the FY2025 annual result was $67000.0, down 54.11% from the prior year.
  • Receivables retreated to $67000.0 in Q4 2025 per ARTV's latest filing, from $79000.0 in the prior quarter.
  • Over five years, Receivables peaked at $1.8 million in Q4 2023 and troughed at $30000.0 in Q2 2025.
  • A 3-year average of $559500.0 and a median of $190000.0 in 2024 frame the typical range for Receivables.
  • On a YoY basis, Receivables climbed as much as 54.11% in 2025 and fell as far as 97.95% in 2025.
  • A 3-year view of Receivables shows it stood at $1.8 million in 2023, then tumbled by 91.7% to $146000.0 in 2024, then plunged by 54.11% to $67000.0 in 2025.
  • Business Quant data shows ARTV's Receivables at $67000.0 in Q4 2025, $79000.0 in Q3 2025, and $30000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 13.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 2.00 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Artiva Biotherapeutics 241.85 Mn 241.85 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 67,000.00
Sep 30, 2025 79,000.00
Jun 30, 2025 30,000.00
Mar 31, 2025 234,000.00
Dec 31, 2024 146,000.00
Sep 30, 2024 701,000.00
Jun 30, 2024 1.46 Mn
Dec 31, 2023 1.76 Mn